CompletedInterventionalNot ApplicableUpdated Nov 27, 2019
Fluorescent Visualization in Early Oral Cancer | NCT02306967 | Trialant
CompletedInterventionalNot ApplicableUpdated May 2, 2018
Fluorescent Visualization in Early Oral Cancer
ClinicalTrials.gov ID
NCT02306967
Lead Sponsor
University of CalgaryOTHER
Overall Status
Completed
Study Type
Interventional
Phase
Not Applicable
Enrollment
40Actual
Last Update Posted
May 2, 2018Actual
Start Date
Sep 2011Actual
Primary Completion Date
Oct 2017Actual
Completion Date
Dec 2017Actual
Brief Summary
Studies from Vancouver show that fluorescent visualization (FV) is a useful method of controlling surgical margins. This early finding will now be confirmed in a national randomized controlled trial.
Oral Squamous Cell Carcinoma or Severe Dysplasia
resection of oral cancer
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
biopsy proven invasive oral cancer or severe dysplasia / Cis
invasive cancer must be T1 or T2
no prior history of oral cancer / treatment of oral cancer